NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.
CASRN: 120279-96-1
Drug Levels and Effects
Summary of Use during Lactation
Limited experience with the use of ophthalmic dorzolamide indicate that it is unlikely to adversely affect the breastfed infant.[1] French guidelines recommend ophthalmic carbonic anhydrase inhibitor drops as a preferred therapy for glaucoma during breastfeeding.[2] To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
A newborn infant was breastfed during maternal therapy with ocular timolol, dipivifrin, dorzolamide, brimonidine and several doses of acetazolamide. The drugs were given immediately following breastfeeding and no apnea or bradycardia was observed in the infant.[3]
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
- 1.
- Belkin A, Chen T, DeOliveria AR, et al. A practical guide to the pregnant and breastfeeding patient with glaucoma. Ophthalmol Glaucoma. 2020;3:79–89. [PubMed: 32672600]
- 2.
- Blumen-Ohana E, Sellem E. J Fr Ophtalmol. 2020;43:63–6. [Pregnancy & glaucoma: SFO-SFG recommendations] [PubMed: 31813552]
- 3.
- Johnson SM, Martinez M, Freedman S. Management of glaucoma in pregnancy and lactation. Surv Ophthalmol. 2001;45:449–54. [PubMed: 11274697]
Substance Identification
Substance Name
Dorzolamide
CAS Registry Number
120279-96-1
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Brimonidine[Drugs and Lactation Database (...]Review Brimonidine. Drugs and Lactation Database (LactMed). 2006
- Review Levobunolol[Drugs and Lactation Database (...]Review Levobunolol. Drugs and Lactation Database (LactMed). 2006
- Review Ketotifen[Drugs and Lactation Database (...]Review Ketotifen. Drugs and Lactation Database (LactMed). 2006
- Review Loteprednol[Drugs and Lactation Database (...]Review Loteprednol. Drugs and Lactation Database (LactMed). 2006
- Review Betaxolol[Drugs and Lactation Database (...]Review Betaxolol. Drugs and Lactation Database (LactMed). 2006
- Dorzolamide - Drugs and Lactation Database (LactMed)Dorzolamide - Drugs and Lactation Database (LactMed)
Your browsing activity is empty.
Activity recording is turned off.
See more...